These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3501949)

  • 1. Anti T11 monoclonal antibodies activate human natural killer (NK) cells via the T11/E rosette receptor.
    Schmidt RE
    Beitr Infusionther Klin Ernahr; 1987; 18():266-71. PubMed ID: 3501949
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM; Zhu HG; Anderer FA
    Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium.
    Timonen T; Ortaldo JR; Vose BM; Henkart M; Alvarez J; Herberman RB
    J Reticuloendothel Soc; 1983 Jan; 33(1):67-80. PubMed ID: 6601190
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of natural killer function through activation of the T11 E rosette receptor.
    Schmidt RE; Michon JM; Woronicz J; Schlossman SF; Reinherz EL; Ritz J
    J Clin Invest; 1987 Jan; 79(1):305-8. PubMed ID: 3098784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors suppress natural killer cell cytolytic activity.
    Ogbomo H; Michaelis M; Kreuter J; Doerr HW; Cinatl J
    FEBS Lett; 2007 Apr; 581(7):1317-22. PubMed ID: 17349632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.
    Hellstrand K; Hermodsson S
    Clin Exp Immunol; 1989 Sep; 77(3):410-6. PubMed ID: 2509116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro activation of NK cytotoxicity with IL-2.
    Ibayashi Y; Tokuda Y; Saks ER; Sarna GP; Golub SH
    Prog Clin Biol Res; 1987; 244():275-85. PubMed ID: 3498954
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
    Kogure T; Mantani N; Goto H; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2002 Aug; 11(4):219-24. PubMed ID: 12396473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.
    López-Botet M; Silva A; Rodríguez J; de Landazuri MO
    J Immunol; 1982 Sep; 129(3):1109-15. PubMed ID: 6213707
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
    J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional surface structures on human natural killer cells.
    Schmidt RE; Hercend T; Schlossman SF; Ritz J
    Klin Wochenschr; 1985 Dec; 63(23):1189-200. PubMed ID: 2418257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain- and age-dependent natural and activated in vitro cytotoxicity in athymic nude mice.
    Radzikowski C; Rygaard J; Budzynski W; Stenvang JP; Schou M; Vangsted A; Zeuthen J
    APMIS; 1994 Jul; 102(7):481-8. PubMed ID: 7917216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligation of ICAM-1 molecules inhibits target cell-induced granule exocytosis of IL-12-activated natural killer cells.
    Cho DH; Song HK; Kang HS; Yoon SR; Lee HG; Pyun KH; Lee WJ; Kim YB; Choi I
    Cell Immunol; 2000 Jan; 199(1):1-7. PubMed ID: 10675269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term culture of LAK cells: expansion and activation signals.
    Ochoa AC; Migliori RJ; Alter BJ; Sondel PM; Simmons RL; Bach FH
    Prog Clin Biol Res; 1987; 244():289-99. PubMed ID: 3116557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation.
    Keever CA; Welte K; Sullivan M; O'Reilly RJ
    Prog Clin Biol Res; 1987; 244():423-32. PubMed ID: 3310004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.